LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
LLY
1,021.52
+0.37%↑
JNJ
195.34
+0.5%↑
ABBV
232.46
-0.34%↓
UNH
332.18
-2.03%↓
AZN
88.54
+0.99%↑
24h
Current
Min
7.21
Max
7.74
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +229.73% upside |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
27 lis 2024, 13:34 UTC
CervoMed Shares Rise 15% on FDA's Orphan Drug Designation for Neflamapimod
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 24.4 USD 229.73%
High 31 USD
Low 19 USD
Based on 5 Wall Street analysts offering 12 month price targets forCervoMed Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
5 ratings
5
Buy
0
Hold
0
Sell
Based on 5 analysts giving stock ratings to CervoMed Inc - Dist in the past 3 months.
$